-
- 抗原 See all PLGLB2 抗体
- PLGLB2 (Plasminogen-Like B2 (PLGLB2))
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This PLGLB2 antibody is un-conjugated
-
应用范围
- ELISA, Immunohistochemistry (IHC)
- 产品特性
- Polyclonal Antibody
- 纯化方法
- Antigen affinity purification
- 免疫原
- Fusion protein of human PLGLB2
- 亚型
- IgG
- Top Product
- Discover our top product PLGLB2 Primary Antibody
-
anti-Plasminogen-Like B2 (PLGLB2) (AA 21-96) antibody
PLGLB2 适用: 人 ELISA, WB, IF, IHC (p) 宿主: 小鼠 Monoclonal 3E6 unconjugated
anti-Plasminogen-Like B2 (PLGLB2) (AA 38-87) antibodyPLGLB2 适用: 人, 猴, 小鼠, 大鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-Plasminogen-Like B2 (PLGLB2) (Middle Region) antibodyPLGLB2 适用: 人, 兔, 犬 WB 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- IHC 1:50-1:300, ELISA 1:5000-1:10000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1.14 mg/mL
- 缓冲液
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C. Avoid freeze / thaw cycles.
-
- 抗原
- PLGLB2 (Plasminogen-Like B2 (PLGLB2))
- 别名
- PLGLB2 (PLGLB2 产品)
- 别名
- PLGP1 antibody, plasminogen-like B2 antibody, PLGLB2 antibody
- 背景
- Cleavage of the serine proteinase plasminogen to form plasmin is the central event in the dissolution of blood clots by the fibrinolytic system. Within the fibrinolytic cascade, the serine proteinases urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) activate the proenzyme plasminogen by cleaving plasminogen to form the fibrinolytically active enzyme plasmin. PLGLB2 (plasminogen-like B2), also known as PLGP1, is a 96 amino acid protein that resembles the N-terminal plasminogen activation peptide, which is released from plasminogen during conversion to plasmin. PLGLB2 may bind to lysine binding sites present in the kringle structures of plasminogen, an event that interfers with the binding of fibrin or α-2 antiplasmin to plasminogen and may result in the localization of activity at sites necessary for extracellular matrix destruction.
- UniProt
- Q02325
-
You are here:
